$NRSN 1.63 ALS study updates soon https://finance.yahoo.com/news/neurosense-enrolls-first-patient-phase-123000179.html https://clinicaltrials.gov/ct2/show/NCT05357950 https://stockcharts.com/c-sc/sc?s=NRSN&p=W&yr=1&mn=10&dy=0&i=t1084022812c&r=1655214612403 NASDAQ 2M nano-float! https://www.neurosense-tx.com https://www.neurosense-tx.com/wp-content/uploads/2021/10/logo_white.png